.png)
TL;DRPrescription-only status (Verschreibungspflicht, Rx) is the legal classification under which a medicine may be dispensed to a consumer only against a valid medical, dental or veterinary prescription. In Germany it is governed by §48 of the Arzneimittelgesetz (AMG) and the Arzneimittelverschreibungsverordnung (AMVV), whose Anlage 1 lists the substances and preparations concerned.
The classification is about dispensing, not about danger in the abstract. A medicine is made prescription-only when its effects, dosage or route of use are not sufficiently known for safe self-medication, or when a physician's oversight is needed to manage the health risk. The prescription is the control point: without it, a pharmacy may not hand the product over.
The anchor is §48 Abs. 1 AMG: medicines containing the substances determined by the ordinance under §48 Abs. 2, or substances whose effects are not yet generally known in medical science, may be dispensed to consumers only on prescription. The ordinance itself is the AMVV. Under §1 AMVV, a medicine is prescription-only if it contains a substance or preparation listed in Anlage 1 to the ordinance, or if such a substance has been added to it. Anlage 1 is the operative list, and it is amended regularly as medical knowledge changes.
German law does not run a simple Rx/OTC binary. It runs a three-step dispensing scale, and "OTC" is not a single legal category but the whole non-prescription range: the pharmacy-only tier plus the general-sale tier.
| Status | What it means | Legal basis | Where it may be sold |
|---|---|---|---|
| Verschreibungspflichtig (Rx) | Dispensed only against a valid prescription | §48 AMG, §1 AMVV, Anlage 1 | Pharmacy, on prescription |
| Apothekenpflichtig (OTC, pharmacy-only) | No prescription needed, but sold only in pharmacies with professional advice | §43 AMG | Pharmacy only |
| Freiverkäuflich (OTC, general sale) | May be sold outside pharmacies, e.g. drugstores | §44 AMG | Pharmacies and other retail |
Two boundaries matter. The line between verschreibungspflichtig and apothekenpflichtig is set by the AMVV (Anlage 1). The line between apothekenpflichtig and freiverkäuflich is set by §43 AMG as the default, with the exemptions for general sale named in §44 AMG and the Verordnung über apothekenpflichtige und freiverkäufliche Arzneimittel. Every prescription-only medicine is by definition also apothekenpflichtig: it can never be freiverkäuflich, because §44 Abs. 3 AMG excludes §48 products from general sale.
Betäubungsmittel and T-Rezept products are a stricter subset within the prescription-only tier, not a separate scale. A Betäubungsmittel (narcotic listed in the annexes of the Betäubungsmittelgesetz) is always prescription-only and additionally requires the three-part BtM-Rezept under the BtMVV. A T-Rezept substance (thalidomide, lenalidomide, pomalidomide) is prescription-only and additionally requires the numbered T-Rezept under §3a AMVV. Both sit on top of prescription-only status: they add a special form and tighter controls, but the base classification is the same Rx status.
Status is not fixed once and for all. It is reviewed, and it can move, most often from Rx to OTC, the so-called "Entlassung aus der Verschreibungspflicht" (OTC-switch).
An OTC-switch therefore reaches practice only once Anlage 1 has been changed. Because the ministerial and Bundesrat steps carry no binding deadline, a switch can take months to years after the committee vote, and a switch is often conditioned on a defined indication, strength or pack size rather than the whole substance.
Reading a product's legal status straight from §48 AMG and Anlage 1 for every article is exactly the manual step an aggregator removes. On pharmazie.com the status is a structured legal flag.
One honest limitation: the flag tells you the current legal classification of an article per PZN. It does not reproduce the reasoning behind it, the AMVV Anlage 1 wording, the indication or strength restrictions attached to a switch, or the status of a pending committee recommendation. §48 AMG, the AMVV and the BfArM committee protocols remain the authority for why a substance carries the status it does.
